Belvedere Trading LLC Cytokinetics Inc Call Options Transaction History

Belvedere Trading LLC

  • $82.2 Billion
  • Q4 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Nov 01, 2024
BUY
$47.86 - $75.05 $311,090 - $487,825
6,500 New
6,500 $352,000
Q2 2024

Aug 09, 2024
BUY
$47.86 - $75.05 $239,300 - $375,250
5,000 Added 333.33%
6,500 $352,000
Q1 2024

May 09, 2024
SELL
$63.75 - $108.06 $1.31 Million - $2.22 Million
-20,500 Reduced 93.18%
1,500 $105,000
Q4 2023

Feb 13, 2024
BUY
$26.88 - $83.49 $430,080 - $1.34 Million
16,000 Added 266.67%
22,000 $1.84 Million
Q3 2023

Oct 27, 2023
BUY
$29.46 - $36.61 $176,760 - $219,660
6,000 New
6,000 $176,000

Others Institutions Holding CYTK

# of Institutions
405
Shares Held
125M
Call Options Held
4.61M
Put Options Held
2.46M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.66B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email